Trials / Recruiting
RecruitingNCT06066918
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
The Effect of Preventional Drug Therapy on Pain Regulation Mechanisms Among Spinal Cord Injury Patients Who Have Yet to Develop Central Pain
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Loewenstein Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
Detailed description
Patients arriving to rehabilitation up to 3 months following SCI will be recruited, if they have not yet developed central pain. Two thirds (the study group) will be treated with Lyrica (Pregabalin75X2) for 3 months. One third (the control group) will not receive preventative treatment. Participants will be followed for central pain development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin 75mg | Pregabalin 75 mg twice a day |
Timeline
- Start date
- 2021-07-13
- Primary completion
- 2026-02-05
- Completion
- 2026-02-05
- First posted
- 2023-10-04
- Last updated
- 2025-06-24
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT06066918. Inclusion in this directory is not an endorsement.